Proxy Votes Now

Home › Funds › Prudential/PGIM › PGIM Jennison Health Sciences Fund

PGIM Jennison Health Sciences Fund (PHLAX) proxy voting record 2025-2026

Fund family: Prudential/PGIM · Filed by PRUDENTIAL SECTOR FUNDS, INC. (CIK 352665) · SEC series S000004380

Share classes and tickers: PHLAX (C000012121), PHLCX (C000012123), PHLQX (C000165347), PHSZX (C000012124), PJHRX (C000110073)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 460 with, 11 against, 1 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 5 FOR, 7 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Prudential/PGIM as a whole

The same two figures as Prudential/PGIM’s manager page (236,459 ballot items across 88 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsPrudential/PGIMItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)97.9%42394.2%197,417
Backed environmental and social shareholder proposals at US companiesn/a513.0%2,860

Where this fund voted differently from most Prudential/PGIM funds

Each ballot item this fund voted is set against the votes of the other Prudential/PGIM funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Prudential/PGIM funds on 11 items (3.7% of the 297 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Prudential/PGIM fundsMgmtResult
CVS Health Corporation2026-05-14Shareholder Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent.ForAGAINST — 16 of 17 Prudential/PGIM fundsAgainst—
CVS Health Corporation2026-05-14Proposal to Approve the Company's 2026 Incentive Compensation Plan.ForAGAINST — 16 of 18 Prudential/PGIM fundsFor—
Gilead Sciences, Inc.2026-04-30Shareholder To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting.ForAGAINST — 15 of 17 Prudential/PGIM fundsAgainstNot approved, 13.1% support
CVS Health Corporation2026-05-14Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation.ForAGAINST — 17 of 20 Prudential/PGIM fundsFor—
UnitedHealth Group Incorporated2026-06-01Election of Directors. Charles BakerAgainstFOR — 12 of 16 Prudential/PGIM fundsAgainst—
Celcuity Inc.2026-05-14To approve, on an advisory basis, named executive officer compensation.ForAGAINST — 3 of 3 Prudential/PGIM fundsForPassed (calculated), 95.1% support
Align Technology, Inc.2026-05-20Advisory Vote to Approve the Compensation of our Named Executive OfficersForAGAINST — 6 of 9 Prudential/PGIM fundsForPassed (calculated), 89.4% support
Enliven Therapeutics, Inc.2026-06-09To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.ForAGAINST — 3 of 4 Prudential/PGIM fundsForApproved, 93.9% support
DENTSPLY SIRONA Inc.2026-06-02Approval, by non-binding vote, of the Company's executive compensation for 2025.ForAGAINST — 3 of 4 Prudential/PGIM fundsForPassed (calculated), 94.6% support
Enliven Therapeutics, Inc.2026-06-09To amend our amended and restated certificate of incorporation, as amended, to increase our authorized shares of common stock from 100,000,000 shares to 200,000,000 shares.ForAGAINST — 2 of 3 Prudential/PGIM fundsForApproved, 99.3% support
DENTSPLY SIRONA Inc.2026-06-02Election of Directors: Betsy D. HoldenForAGAINST — 2 of 3 Prudential/PGIM fundsForPassed (calculated), 86.0% support

Download all 11 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 71.6% of this fund’s 472 such votes could be given a sector; the other 134 (28.4%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care287103.5%
Industrials3400.0%
Consumer Staples1715.9%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections2570
Audit-related530
Say-on-Pay410
Capital Structure400
Compensation371
Corporate Governance373
Shareholder Rights and Defenses72
Other Social Issues43
Diversity, Equity, and Inclusion11
Human Rights or Human Capital/workforce11

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Eli Lilly and CompanyMay 4, 2026$333M102
Merck & Co., Inc.May 26, 2026$102M183
UnitedHealth Group IncorporatedJune 1, 2026$88M121
Thermo Fisher Scientific Inc.May 20, 2026$87M130
argenx SENovember 18, 2025$75M10
Gilead Sciences, Inc.April 30, 2026$72M153
Vertex Pharmaceuticals IncorporatedMay 13, 2026$56M151
argenx SEMay 6, 2026$56M120

Notable votes against management

MeetingCompanyProposalFundMgmt
May 4, 2026Eli Lilly and CompanyShareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
June 1, 2026UnitedHealth Group IncorporatedIf properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposalForAgainst
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalForAgainst
May 13, 2026Vertex Pharmaceuticals IncorporatedShareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent. Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalForAgainst

Search this fund’s votes by company

478 ballot items at 50 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, PGIM Jennison Health Sciences Fund (PHLAX) voted at 50 shareholder meetings of 49 companies, on 478 ballot items in all. Where management made a recommendation, the fund followed it on 97.5% of the items and voted against it 11 times. Its most frequent area of disagreement was corporate governance (3 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals more often than Prudential/PGIM's funds as a whole (97.9% against 94.2%). It voted differently from most Prudential/PGIM funds on 11 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Prudential/PGIM’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.